Cargando…
The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment
Background and objectives: Anemia is common in multiple myeloma (MM) and is caused by a complex pathomechanism, including impaired iron homeostasis. Our aim is to evaluate the biomarkers of iron turnover: serum soluble transferrin receptor (sTfR) and hepcidin-25 in patients at various stages of MM i...
Autores principales: | Banaszkiewicz, Małgorzata, Małyszko, Jolanta, Batko, Krzysztof, Koc-Żórawska, Ewa, Żórawski, Marcin, Dumnicka, Paulina, Jurczyszyn, Artur, Woziwodzka, Karolina, Maleszka, Aleksandra, Krzanowski, Marcin, Kraśniak, Andrzej, Drożdż, Ryszard, Krzanowska, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955231/ https://www.ncbi.nlm.nih.gov/pubmed/35334593 http://dx.doi.org/10.3390/medicina58030417 |
Ejemplares similares
-
Transgelin-2 in Multiple Myeloma: A New Marker of Renal Impairment?
por: Woziwodzka, Karolina, et al.
Publicado: (2021) -
Renal Impairment Detectors: IGFBP-7 and NGAL as Tubular Injury Markers in Multiple Myeloma Patients
por: Woziwodzka, Karolina, et al.
Publicado: (2021) -
Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple Myeloma
por: Banaszkiewicz, Małgorzata, et al.
Publicado: (2020) -
New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia
por: Banaszkiewicz, Małgorzata, et al.
Publicado: (2019) -
New Markers of Renal Failure in Multiple Myeloma and Monoclonal Gammopathies
por: Woziwodzka, Karolina, et al.
Publicado: (2020)